Modafinil is a drug that promotes wakefulness and is licensed for treating people who experience excessive sleepiness due to narcolepsy. Research has suggested that it may be an effective treatment for multiple sclerosis fatigue. However, following the findings of a safety review, the European Medicines Agency recommended that the use of modafinil should only be associated with narcolepsy.